Cover Image
Market Research Report
Product code 
1004019

Breast Cancer Diagnostics Global Market Report 2021: COVID 19 Growth And Change to 2030

Published: Pre-Order | The Business Research Company | 175 Pages | Delivery time: 2-10 business days

Price

Back to Top
Breast Cancer Diagnostics Global Market Report 2021: COVID 19 Growth And Change to 2030
Published: Pre-Order
The Business Research Company
Content info: 175 Pages
Delivery time: 2-10 business days
  • ALL
  • Description
  • Table of Contents
Description

Breast Cancer Diagnostics Global Market Report 2021: COVID 19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global breast cancer diagnostics market.

This report focuses on breast cancer diagnostics market which is experiencing strong growth. The report gives a guide to the breast cancer diagnostics market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the breast cancer diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Breast Cancer Diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider breast cancer diagnostics market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The breast cancer diagnostics market section of the report gives context. It compares the breast cancer diagnostics market with other segments of the breast cancer diagnostics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, breast cancer diagnostics indicators comparison.

Scope

Markets Covered:1)By Type: Imaging; Biopsy; Genomic Tests; Blood Tests; Others 2) By Technology: Fluorescent In Situ Hybridization (FISH); Comparative Genomic Hybridization (CGH); Immunohistochemical (IHC); Other Technologies 3) By Cancer Type: BRCA Breast Cancer; ER & PR Breast Cancer; HER 2 Breast Cancer; EGFR Mutation Test Breast Cancer; Others 4) By Diagnostic Type: Ionizing Breast Imaging Technologies; Non-ionizing Imaging Technologies 5) By End Users: Hospitals and Clinics; Cancer Research Centers; Diagnostic Laboratories; Ambulatory Surgical Centers

Companies Mentioned:Abbott Laboratories; Myriad Genetics, Inc.; Hologic, Inc.; Koninklijke Philips N.V.; Fujifilm Holdings Corporation

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

Table of Contents

1. Executive Summary

2. Breast Cancer Diagnostics Market Characteristics

3. Breast Cancer Diagnostics Market Trends And Strategies

4. Impact Of COVID-19 On Breast Cancer Diagnostics

5. Breast Cancer Diagnostics Market Size And Growth

  • 5.1. Global Breast Cancer Diagnostics Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Breast Cancer Diagnostics Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Breast Cancer Diagnostics Market Segmentation

  • 6.1. Global Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Imaging
  • Biopsy
  • Genomic Tests
  • Blood Tests
  • Others
  • 6.2. Global Breast Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Fluorescent In Situ Hybridization (FISH)
  • Comparative Genomic Hybridization (CGH)
  • Immunohistochemical (IHC)
  • Other Technologies
  • 6.3. Global Breast Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • BRCA Breast Cancer
  • ER & PR Breast Cancer
  • HER 2 Breast Cancer
  • EGFR Mutation Test Breast Cancer
  • Others
  • 6.4. Global Breast Cancer Diagnostics Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Ionizing Breast Imaging Technologies
  • Non-ionizing Imaging Technologies
  • 6.5. Global Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals and Clinics
  • Cancer Research Centers
  • Diagnostic Laboratories
  • Ambulatory Surgical Centers

7. Breast Cancer Diagnostics Market Regional And Country Analysis

  • 7.1. Global Breast Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Breast Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Breast Cancer Diagnostics Market

  • 8.1. Asia-Pacific Breast Cancer Diagnostics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Breast Cancer Diagnostics Market

  • 9.1. China Breast Cancer Diagnostics Market Overview
  • 9.2. China Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Breast Cancer Diagnostics Market

  • 10.1. India Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Breast Cancer Diagnostics Market

  • 11.1. Japan Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Breast Cancer Diagnostics Market

  • 12.1. Australia Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Breast Cancer Diagnostics Market

  • 13.1. Indonesia Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Breast Cancer Diagnostics Market

  • 14.1. South Korea Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Breast Cancer Diagnostics Market

  • 15.1. Western Europe Breast Cancer Diagnostics Market Overview
  • 15.2. Western Europe Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Breast Cancer Diagnostics Market

  • 16.1. UK Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Breast Cancer Diagnostics Market

  • 17.1. Germany Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Breast Cancer Diagnostics Market

  • 18.4. France Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Breast Cancer Diagnostics Market

  • 19.1. Eastern Europe Breast Cancer Diagnostics Market Overview
  • 19.2. Eastern Europe Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Breast Cancer Diagnostics Market

  • 20.1. Russia Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Breast Cancer Diagnostics Market

  • 21.1. North America Breast Cancer Diagnostics Market Overview
  • 21.2. North America Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Breast Cancer Diagnostics Market

  • 22.1. USA Breast Cancer Diagnostics Market Overview
  • 22.2. USA Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Breast Cancer Diagnostics Market

  • 23.1. South America Breast Cancer Diagnostics Market Overview
  • 23.2. South America Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Breast Cancer Diagnostics Market

  • 24.1. Brazil Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Breast Cancer Diagnostics Market

  • 25.1. Middle East Breast Cancer Diagnostics Market Overview
  • 25.2. Middle East Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Breast Cancer Diagnostics Market

  • 26.1. Africa Breast Cancer Diagnostics Market Overview
  • 26.2. Africa Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Breast Cancer Diagnostics Market Competitive Landscape And Company Profiles

  • 27.1. Breast Cancer Diagnostics Market Competitive Landscape
  • 27.2. Breast Cancer Diagnostics Market Company Profiles
    • 27.2.1. Abbott Laboratories
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Myriad Genetics Inc
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Hologic Inc
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Koninklijke Philips N.V.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Fujifilm Holdings Corporation
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Breast Cancer Diagnostics Market

29. Breast Cancer Diagnostics Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer